trofosfamide has been researched along with Lymphoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bechrakis, NE; Fischer, L; Jahnke, K; Korfel, A; Kraemer, DF; Thiel, E; Willerding, G | 1 |
Frank, R; Latz, D; Nassar, N | 1 |
Bechrakis, NE; Coupland, SE; Jahnke, K; Komm, J; Korfel, A; Stein, H; Thiel, E | 1 |
Liffers, R | 1 |
Helsing, MD | 1 |
Aiginger, P; Kühböck, J; Pötzi, P | 1 |
1 review(s) available for trofosfamide and Lymphoma
Article | Year |
---|---|
Trofosfamide in the palliative treatment of cancer: a review of the literature.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Lymphoma; Neoplasms; Palliative Care; Sarcoma; Treatment Outcome | 2004 |
2 trial(s) available for trofosfamide and Lymphoma
Article | Year |
---|---|
Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cyclophosphamide; Eye Neoplasms; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Retinal Neoplasms; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Vitreous Body | 2006 |
Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Salvage Therapy | 1997 |
3 other study(ies) available for trofosfamide and Lymphoma
Article | Year |
---|---|
Ifosfamide or trofosfamide in patients with intraocular lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cyclophosphamide; Eye Neoplasms; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Middle Aged; Survival Analysis; Survivors; Time Factors; Vitrectomy | 2009 |
[Treatment of advanced non-Hodgkin's lymphoma using adriblastin and endoxan as well as ixoten].
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male | 1980 |
[Ixoten therapy in malignant lymphomas].
Topics: Adult; Aged; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Plasmacytoma | 1979 |